SBIR Phase II Enhanced: How DOD Matching Funds Work

For every dollar of private investment you bring to the table, the Department of Defense will put up a dollar of its own — up to $750,000. That is the core proposition of SBIR Phase II Enhanced, a DoD-specific matching program that has quietly become one of the most efficient funding mechanisms in the federal innovation ecosystem. While the recent Strategic Breakthrough Awards have attracted attention with their $30 million ceiling, Phase II Enhanced has been operational for years, moving smaller but meaningful sums to companies that can demonstrate both technical progress and investor confidence.

The catch, as always with matching programs, is that you need the private capital first.

The Mechanics of Phase II Enhanced

Phase II Enhanced is not a separate competition. It is an augmentation to an existing Phase II award, available exclusively through the Department of Defense. If you hold an active DoD SBIR Phase II contract, you can apply for Enhanced funding by demonstrating that a third party — venture capital firm, angel investor, corporate partner, or strategic acquirer — has committed investment in your company or technology.

The matching ratio is straightforward: one federal dollar for every private dollar invested, capped at $750,000 in additional government funding. Combined with a standard Phase II award of up to $1.7 million, Enhanced funding can push total government support past $2.4 million for a single technology development effort.

Applications go through the Defense SBIR/STTR Innovation Portal (DSIP). The evaluation focuses on two things: the credibility of the investment commitment and the commercial potential of the technology. A signed term sheet or executed investment agreement carries far more weight than a letter of interest. Agencies want to see that the private capital is real, not contingent on the Enhanced award itself.

Processing timelines vary by component. Army, Navy, Air Force, and defense agencies each manage their own Enhanced programs, and turnaround can range from 60 days to six months depending on the contracting office and the complexity of the investment arrangement. Plan accordingly — if your Phase II period of performance is winding down, start the Enhanced application early.

What Counts as Private Investment

The definition of qualifying investment is broader than many applicants realize, but it has firm boundaries.

Equity investment is the most common form. A venture capital round, angel investment, or corporate strategic investment where cash flows into the company in exchange for equity directly satisfies the matching requirement. The investment must be directed toward the SBIR-funded technology or its commercialization — general operating capital invested before the Phase II award typically does not qualify.

Binding contracts also count. A customer purchase order, licensing agreement with guaranteed minimums, or a funded development contract from a commercial partner can serve as the match. The commitment must be firm and documented, with funds flowing during or after the Enhanced period of performance.

What does not count: in-kind contributions, SBIR or STTR funding from any agency, other federal grants, or speculative revenue projections. A term sheet conditional on the Enhanced award creates a circular dependency that evaluators will reject.

For companies pursuing the SBIR pathway across multiple agencies, note that Enhanced is DoD-only. NIH, NSF, DOE, and other agencies do not offer equivalent matching programs at the Phase II level, though the new Strategic Breakthrough Awards will eventually provide a cross-agency option at much higher dollar amounts.

How Enhanced Differs from Strategic Breakthrough Awards

Both programs use matching funds to accelerate commercialization, but they serve different stages and scales. Understanding the distinction matters for planning your funding trajectory. The DoD SBIR guide covers both programs in the context of the full DoD pipeline.

Phase II Enhanced is incremental. It adds $750,000 to an existing Phase II award based on demonstrated private investment. The technology is still in development. The purpose is to accelerate the transition from prototype to product by bringing commercial capital alongside government R&D funding.

Strategic Breakthrough Awards are transformational. They offer up to $30 million for companies that have completed Phase II and can demonstrate significant commercial traction. The matching requirement is 100% — dollar for dollar with no cap adjustment — and the evaluation emphasizes deployment-ready technology with established market demand.

The practical implication: Phase II Enhanced is your bridge from development to early commercialization. Strategic Breakthrough Awards are your bridge from early commercialization to scale. A company that uses Enhanced funding to build a production-ready product and generate initial revenue is precisely the profile that will compete well for Breakthrough Awards two or three years later.

Positioning for Enhanced Funding

The strongest Enhanced applications share three characteristics: the investment is committed before the application is submitted, the commercial thesis is clear, and the Phase II technical progress supports the investment narrative.

Start investor conversations early in your Phase II. The best time to secure an investment commitment is when you have 12 to 18 months of Phase II performance behind you — enough to show technical progress, but early enough that the Enhanced funding will meaningfully accelerate your timeline. Investors who understand the SBIR ecosystem recognize that Enhanced matching effectively doubles their capital efficiency; use that as a selling point.

Structure the investment to maximize the match. If an investor is willing to commit $1 million, the Enhanced match adds $750,000 in government funding for a total of $1.75 million in additional capital. If they are willing to commit $500,000, the match adds $500,000 for $1 million total. The cap is on the government side, so investments above $750,000 still qualify but only match up to the ceiling.

Document everything before you apply. The DSIP application requires evidence of the investment commitment — executed agreements, wire transfer confirmations, or signed term sheets with clear closing timelines. Verbal commitments, even from reputable investors, will not survive the evaluation. If your investor needs time to complete due diligence, wait until the paperwork is signed.

The Investor Perspective: Why the Match Matters

From the investor side, Phase II Enhanced is a de-risking mechanism that is hard to replicate in the private market. A $500,000 investment that triggers $500,000 in government matching means the company receives $1 million in capital for the price of $500,000 in dilution. The government funding is non-dilutive — it does not take equity, does not sit on the cap table, and does not impose governance requirements beyond the existing Phase II contract terms.

For venture capital firms evaluating defense technology startups, the Enhanced match also signals agency validation. A DoD contracting officer approving Enhanced funding is implicitly confirming that the technology has military relevance and commercial potential — the same factors that drive Phase III procurement and production contracts.

Related SBIR reading:

• SBIR Grant Guide 2026
• SBIR Phase I vs Phase II: Requirements and Strategy
• SBIR Commercialization Plan Examples

Companies that understand this dynamic and communicate it clearly to potential investors gain a meaningful fundraising advantage — and Granted can help you build the commercialization narrative that connects your Phase II results to the investment case.